Exploration of Drug Science

🔥 New Special Issue Online 🔥Call for papers! 📌 Title: The Rise of Targeted Covalent Inhibitors in Drug Discovery, https://lnkd.in/gCS-vc3B ✍ Guest Editors: 👨🎓 Prof. F. Javier Luque Full Professor, Institute of Biomedicine, University of Barcelona, Barcelona, Spain 👨🎓 Prof. Jerônimo Lameira Associate Professor, Institute of Biological Sciences, Federal University of Pará, Belém, Pará, Brazil This special issue aims to gather high quality research or review papers on the design, synthesis and pharmacological application of covalent inhibitors, including both in silico and experimental studies addressing the strategy to select appropriate warheads and their attachment to the chemical scaffold of the bioactive compound, the modulation of the chemical reactivity and target selectivity, the mechanism of covalent modification and the optimization of the pharmacological profile, with the ultimate goal of enhancing the medicinal chemistry toolbox in drug discovery of covalent inhibitors. We are actively seeking submissions for this special issue. Publishing with us offers unique benefits, including: 👉 free publication before 2028; 👉 authors hold copyright; 👉 the reward for high-impact articles ranging from $300 -$500. Researchers are invited to contribute their findings and join the topic driving this exciting field forward! ❣ If you are interested, please don’t hesitate to contact me! 🔗Submission Online: https://eds.aressystem.com 💌 For other information, please contact us: [email protected]

🔥 New Article sharing! 📚 Title: FDA’s approval of resmetirom (Rezdiffra): a breakthrough in MASH management ✍ Authors: Muhammad Mazhar Azam, Sameen Mukhtar, Muhammad Haris, Fatima Laique, Suhaina Amir, Mubashir Mohiuddin, Bibek Giri 💡Keywords: #MASH, #NAFLD, #resmetirom, #liver, #fibrosis, #thyroid 🔗 Full text: https://lnkd.in/g8NVQBRu

🔥 New special issue sharing, the opening article have been published! 📌 Title: Leveraging the FDA-Approved Kinase Inhibitors to Treat Neurological Disorders ✍ Guest Editor: Prof. Dazhi Liu E-Mail School of Medicine, University of California Davis, Sacramento, CA, USA 🔗 Special Issue link: https://lnkd.in/ggkDChKJ As a promising open access journal , EDS has been endeavoring to publish high-quality research and disseminate such content without barrier. We cordially welcome your high-quality articlespublished on our journal EDS (hashtag #ZeroFee, hashtag #OpenAccess, hashtag #GoogleScholar indexing). ❣ If you are interested, please don’t hesitate to contact me! 🔗Submission Online: https://eds.aressystem.com 💌 For other information, please contact us: [email protected]

🔥 New Article sharing! 📚 Title: FDA-approved kinase inhibitors: a promising therapeutic avenue for traumatic brain injury ✍ Authors: Dezhu Gao, Yu Shi, Zhiliang Wang, Weiming Liu 💡Keywords: #TraumaticBrainInjury, #KinaseInhibitor, #neuroinflammation, #NeurobiologicalDeficits 🔗 Full text: https://lnkd.in/g2Jh5av7 ❣ Belongs to the special issue: Leveraging the FDA-Approved Kinase Inhibitors to Treat Neurological Disorders, https://lnkd.in/ggkDChKJ

🔥 Hot special issue sharing, 7 popular articles have been published! 📌 Title: Bioactive Peptides: Pioneering Innovations in Latin American Research, https://lnkd.in/es-6q_w5 ✍ Guest Editor: Fanny Guzmán Quimbayo, Pontifical Catholic University of Valparaíso, Chile Fernando Albericio, Universities of KwaZulu-Natal, South Africa; Universidad de Barcelona, Spain As a promising open access journal , EDS has been endeavoring to publish high-quality research and disseminate such content without barrier. We cordially welcome your high-quality articlespublished on our journal EDS (#ZeroFee, #OpenAccess, #GoogleScholar indexing). ❣ If you are interested, please don’t hesitate to contact me! 🔗Submission Online: https://eds.aressystem.com 💌 For other information, please contact us: [email protected]

🔥 New Article sharing! 📚 Title: Potential use of peptides mimicking CRAC/CARC domains as antivirulence therapies to inhibit RTX toxins activities ✍ Authors: Vanesa Herlax 💡Keywords: #RTXtoxins, #antivirulencetherapies, #CRAC, #CARCdomains, #HlyA #E. coli 🔗 Full text: https://lnkd.in/gGKA45Qb ❣ Belongs to the special issue: Bioactive Peptides: Pioneering Innovations in Latin American Research, https://lnkd.in/es-6q_w5

🔔 New Review Published Online 🔔 📣 Technetium-99m-labeled peptides and their applications in radio imaging: advancements in Latin American research ✒ Authors: Vaezeh Fathi Vavsari, Saeed Balalaie ⭐ Keywords: #Technetium99m,#peptide, #solidphasesynthesis, #imaging 📰 Read the full article: https://lnkd.in/g-mUrz5U 📑 PDF: https://lnkd.in/gcR_tfWv

🔥 Call for paper! 📌 Title: Mimicking Nature: Biomimetics as Tools for Diagnosis and Therapeutics, https://lnkd.in/gNP3GtGg ✍ Guest Editor: Prof. Rosario González-Muñiz, Medicinal Chemistry Institute (IQM-CSIC), Spain Dr. Diego Núñez-Villanueva, Medicinal Chemistry Institute (IQM-CSIC), Spain This special issue explores innovative applications of biomimetic principles in diagnostic and therapeutic technologies, aiming to advance healthcare by drawing inspiration from nature’s designs. We are actively seeking submissions for this special issue. Publishing with us offers unique benefits, including: 👉 free publication before 2028; 👉 authors hold copyright; 👉 the reward for high-impact articles ranging from $300 -$500. Researchers are invited to contribute their findings and join the topic driving this exciting field forward! ❣ If you are interested, please don’t hesitate to contact me! 🔗Submission Online: https://eds.aressystem.com 💌 For other information, please contact us: [email protected]

🔔 New Review Published Online 🔔 📣 Bio-mimetic strategies to re-activate apoptotic cell death for cancer treatments ✒ Authors: Andrea Venerando, Denise Lovison, Rossella De Marco ⭐ Keywords: #Apoptosis, #BH3mimetics, #SMAC/DIABLO, #kinase inhibition, #peptidomimetics, #nanoparticles 📰 Read the full article: https://lnkd.in/g9mV8aAn 📑 PDF: https://lnkd.in/gb_i9GzG

🔥 Hot special issue sharing, 4 popular articles have been published! 📌 Title: Remedial benefits of natural products in inflammation and cancer, https://lnkd.in/g6mHjChi ✍ Guest Editor: Noah Isakov, University of the Negev, Israel Ruby John Anto, Institute of Advanced Virology, India As a promising open access journal , EDS has been endeavoring to publish high-quality research and disseminate such content without barrier. We cordially welcome your high-quality articlespublished on our journal EDS (hashtag #ZeroFee, hashtag #OpenAccess and hashtag #GoogleScholar indexing). ❣ If you are interested, please don’t hesitate to contact me! 🔗Submission Online: https://eds.aressystem.com 💌 For other information, please contact us: [email protected]